EA201000063A1 - Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе - Google Patents

Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе

Info

Publication number
EA201000063A1
EA201000063A1 EA201000063A EA201000063A EA201000063A1 EA 201000063 A1 EA201000063 A1 EA 201000063A1 EA 201000063 A EA201000063 A EA 201000063A EA 201000063 A EA201000063 A EA 201000063A EA 201000063 A1 EA201000063 A1 EA 201000063A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
compositions based
basis
functions
thrombin inhibitors
Prior art date
Application number
EA201000063A
Other languages
English (en)
Inventor
Елена Ивановна Синауридзе
Фазоил Иноятович АТАУЛЛАХАНОВ
Андрей Александрович Бутылин
Владимир Борисович СУЛИМОВ
Алексей Николаевич РОМАНОВ
Алексей Алексеевич Боголюбов
Юрий Владимирович Кузнецов
Ирина Владимировна Грибкова
Александр Сергеевич Горбатенко
Ольга Анатольевна Кондакова
Original Assignee
Общество С Ограниченной Ответственностью "Бионика"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Бионика" filed Critical Общество С Ограниченной Ответственностью "Бионика"
Publication of EA201000063A1 publication Critical patent/EA201000063A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение описывает новые химические соединения, применение этих соединений в качестве ингибиторов тромбина и фармацевтические композиции на их основе и может быть использовано для лечения и профилактики тромбинзависящих тромбоэмболических событий, а также в научно-исследовательских целях.
EA201000063A 2007-06-28 2008-06-27 Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе EA201000063A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2007124201/04A RU2354647C2 (ru) 2007-06-28 2007-06-28 Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
PCT/RU2008/000400 WO2009002228A2 (en) 2007-06-28 2008-06-27 New thrombin function compounds and pharmaceutical compositions based on them

Publications (1)

Publication Number Publication Date
EA201000063A1 true EA201000063A1 (ru) 2010-06-30

Family

ID=40186195

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000063A EA201000063A1 (ru) 2007-06-28 2008-06-27 Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе

Country Status (11)

Country Link
US (1) US20100324058A1 (ru)
EP (1) EP2178838A2 (ru)
JP (1) JP2010531352A (ru)
KR (1) KR20100039867A (ru)
CN (1) CN101861304A (ru)
AU (1) AU2008269712B2 (ru)
CA (1) CA2693226A1 (ru)
EA (1) EA201000063A1 (ru)
RU (1) RU2354647C2 (ru)
UA (1) UA98970C2 (ru)
WO (1) WO2009002228A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2353619C2 (ru) * 2007-06-28 2009-04-27 Общество С Ограниченной Ответственностью "Бионика" Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции
WO2013048787A1 (en) 2011-09-26 2013-04-04 Yes, Inc. Novel hemostatic compositions and dressings for bleeding
WO2013056116A1 (en) * 2011-10-12 2013-04-18 The Trustees Of Columbia University In The City Of New York Hemostatic dressing for arterial bleeding
FR3030516B1 (fr) * 2014-12-19 2019-12-27 Galderma Research & Development Derives sulfonamides bicycles en tant qu'agonistes inverses du recepteur gamma orphelin associe aux retinoides ror gamma (t)
RU2685261C1 (ru) * 2018-04-05 2019-04-17 Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" Вещество 4-амино-1-{ 2-[3-метил-5-(бензолсульфонилокси)фенокси] этил} -пиридиний хлорид, обладающее свойствами биологически активного агента, влияющими на естественно текущие процессы свертываемости крови млекопитающих, антикоагулянт на его основе и способ его получения путем химического синтеза

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1469906A (en) 1921-08-26 1923-10-09 Augie L Hansen Tufting needle
DE1245937B (ru) * 1964-09-09 1967-08-03
US5089634A (en) * 1984-08-20 1992-02-18 Georgia Tech Research Corporation Isocoumarins with cationic substituents
US5214052A (en) 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
JPH0341065A (ja) * 1989-07-06 1991-02-21 Morishita Pharmaceut Co Ltd アリールオキシアルキルイソチオウレア臭化水素酸塩類
JP3084458B2 (ja) * 1991-11-08 2000-09-04 コニカ株式会社 ハロゲン化銀写真感光材料
TW257757B (ru) * 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
IL109319A0 (en) * 1993-04-27 1994-07-31 Du Pont Merck Pharma Amidino and guanidino substituted boronic acid compounds
US5510369A (en) 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
DE4430757A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue 4-Aminopyridazine, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
SE9404196D0 (sv) 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
US5792769A (en) * 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
ATE341317T1 (de) * 1996-03-29 2006-10-15 Ortho Mcneil Pharm Inc Amidinohydrazone als protease-inhibitoren
EP0927035A4 (en) * 1996-09-13 2002-11-13 Merck & Co Inc THROMBIN INHIBITORS
US5792779A (en) 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof
UA75093C2 (en) * 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
JP4896387B2 (ja) * 2003-09-30 2012-03-14 武田薬品工業株式会社 チアゾリン誘導体およびその用途
DE602005001696T2 (de) * 2004-03-02 2008-04-10 F. Hoffmann-La Roche Ag 4-(sulfanylpyrimidin-4-ylmethyl)morpholin-derivate und verwandte verbindungen als gaba-rezeptorliganden zur behandlung von angst, depression und epilepsie
US8546583B2 (en) * 2006-05-31 2013-10-01 Abbvie Inc. Compounds as cannabinoid receptor ligands and uses thereof
RU2353619C2 (ru) * 2007-06-28 2009-04-27 Общество С Ограниченной Ответственностью "Бионика" Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции

Also Published As

Publication number Publication date
EP2178838A2 (en) 2010-04-28
JP2010531352A (ja) 2010-09-24
UA98970C2 (ru) 2012-07-10
CN101861304A (zh) 2010-10-13
RU2007124201A (ru) 2009-01-10
CA2693226A1 (en) 2008-12-31
KR20100039867A (ko) 2010-04-16
AU2008269712A8 (en) 2010-04-15
AU2008269712B2 (en) 2013-01-17
WO2009002228A3 (en) 2009-03-12
US20100324058A1 (en) 2010-12-23
WO2009002228A2 (en) 2008-12-31
RU2354647C2 (ru) 2009-05-10
AU2008269712A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
EA201070247A1 (ru) Ингибиторы протеасом
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
EA201170295A1 (ru) ИНГИБИТОРЫ сМЕТ
EA201100037A1 (ru) Органические соединения
EA201190224A1 (ru) Ингибиторы гепатита c, содержащие конденсированные кольца
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
NO20081636L (no) FAP - inhibitorer
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
CY1116435T1 (el) Ενωσεις βορονικου εστερα και φαρμακευτικες συνθεσεις αυτων
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
EA201070278A1 (ru) Ингибиторы гамма-секретазы
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
EA201170772A1 (ru) Органические соединения
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
EA200970156A1 (ru) Пиридизиноновые производные
EA200901490A1 (ru) Химические соединения
EA201070422A1 (ru) Производные оксадиазола
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
EA201201665A1 (ru) Новые соединения
EA200901486A1 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR
EA200901212A1 (ru) 3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний